In a study conducted by Cho et al., the prolactin level was monitored in patients with cystic fibrosis receiving domperidone, almost 45 percent of the patients had values above the normal range (<20 ng/dl), and dosage adjustment or discontinuation was required in only 14 percent of patients with raised prolactin levels [24]. The gene discussed is PRL; the disease is cystic fibrosis.